• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Ex-Cyberonics rep asks appeals court to reinstate whistleblower suit

Ex-Cyberonics rep asks appeals court to reinstate whistleblower suit

November 9, 2016 By Fink Densford

cyberonics-1x1A former Cyberonics (NSDQ:CYBX) sales rep this week asked the 1st Circuit Court of Appeals to reinstate a File Claims Act suit, claiming his allegations were sufficient to show that the company pressed its reps to offer unnecessary epilepsy implant procedures.

The plaintiff, Andrew Hagerty, worked for Cyberonics between 2010 and 2012 and claims that the company urged its representatives to use “fraudulent techniques such as falsifying diagnostic information,” as well as supporting unnecessary replacement procedures for its VNS devices, according to court documents.

Hagerty sued the Houston, Texas-based company in 2012, alleging that Cyberonics canned him after he refused to sell unneeded replacement batteries for implanted pulse generators designed to treat epilepsy. The suit was dismissed in February, 2013.

The lawsuit, filed in the U.S. District Court for Massachusetts, accused Cyberonics of changing its sales policy to allow commissions on the sale of replacement batteries. Hagerty, whose son was implanted with 1 of the devices to control his epileptic seizures, alleged that the Cyberonics procedures “not only had been illegal, in violation of FDA policy and regulations, and contrary to the FDA’s summary of approval but also subjected patients to unnecessary surgery,” according to court documents.

“Many Cyberonics salespersons simply disregarded the health and welfare of patients who would receive replacement batteries. They subjected these individuals to unnecessary surgery only as part of an effort to earn more money,” according to the lawsuit. “In fact, Cyberonics had indicated that salespersons should not do so. Cyberonics had issued an email setting forth that very direction. The email stated: ‘Important reminder: it is the neurologist’s decision to determine if a patient is at End of Service or may need a prophylactic replacement. This report should not be used to make any suggestions or assumptions as such by Cyberonics.’”

After Hagerty was allegedly told to boost his sales of replacement batteries using allegedly illegal practices, Cyberonics fired him, according to the lawsuit.

Filed Under: Business/Financial News, Legal News, Neuromodulation/Neurostimulation Tagged With: cyberonics

More recent news

  • Neuronetics names Steven Pfanstiel chief financial officer
  • Medtronic to distribute Future Medical’s peripheral guidewires
  • AtriCure completes enrollment in stroke prevention trial
  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy